Protection of Stratospheric Ozone: Request for Critical Use Exemption Applications for the Years 2008 and 2009, 24698-24701 [E6-6256]
Download as PDF
24698
Federal Register / Vol. 71, No. 80 / Wednesday, April 26, 2006 / Notices
The Applicant proposes to make no
more than two pre-emergence broadcast
applications at a rate of 1.0–2.0 lbs of
product per acre (0.5–1.0 lbs acre (a.i.)
on 8,000 acres of cranberries. No more
than 2.0 lbs of product/acre/season 1.0
lbs a.i. may be made as a result of single
or split application.
This notice does not constitute a
decision by EPA on the application
itself. The regulations governing section
18 of FIFRA require publication of a
notice of receipt of an application for a
specific exemption proposing a use
which has been requested in 3 or more
previous years, and a petition for
tolerance has not yet been submitted to
the Agency.
As noted above, the Agency is
eliminating the comment period due to
the urgent nature of an emergency
situation and the very narrow and
extremely limited use being requested.
Nonetheless, interested parties may still
contact the Agency with comments
about this notice and treatment
program.
List of Subjects
Environmental protection, Pesticides
and pests.
Dated: April 17, 2006.
Donald R. Stubbs,
Acting Director, Registration Division, Office
of Pesticide Programs.
[FR Doc. E6–6288 Filed 4–25–06; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OAR–2003–0017; FRL–8162–2]
Protection of Stratospheric Ozone:
Request for Critical Use Exemption
Applications for the Years 2008 and
2009
Environmental Protection
Agency (EPA).
ACTION: Notice of solicitation of
applications and information on
alternatives.
wwhite on PROD1PC61 with NOTICES
AGENCY:
SUMMARY: EPA is soliciting applications
for the critical use exemption from the
phaseout of methyl bromide for 2009
and beyond. In addition, those
applicants who missed last year’s
deadline to apply for a critical use
exemption for the year 2008 may file a
supplemental application in response to
the notice. This exemption is an annual
exemption and all entities interested in
obtaining a critical use exemption must
provide EPA with technical and
economic information to support a
‘‘critical use’’ claim, and must do so by
VerDate Aug<31>2005
16:58 Apr 25, 2006
Jkt 208001
the deadline specified in this notice
even if they have previously applied for
an exemption. This notice also invites
interested parties to provide EPA with
new data on the technical and economic
feasibility of methyl bromide
alternatives.
Applications for the critical use
exemption must be postmarked on or
before July 10, 2006. Applications for an
exemption are due one month earlier to
EPA this year to reflect the compressed
schedule for review of applications in
2007.
DATES:
Applications for the methyl
bromide critical use exemption should
be submitted in duplicate (two copies)
by mail to: U.S. Environmental
Protection Agency, Office of Air and
Radiation, Stratospheric Protection
Division, Attention: Marta Montoro/
Methyl Bromide Review Team, Mail
Code 6205J, 1200 Pennsylvania Ave.,
NW., Washington, DC 20460 or by
courier delivery (other than U.S. Post
Office overnight) to: U.S. Environmental
Protection Agency, Office of Air and
Radiation, Stratospheric Protection
Division, Attention: Marta Montoro/
Methyl Bromide Review Team, 1310 L
St., NW., Room 827L, Washington, DC
20005. EPA also encourages users to
submit their applications electronically
to Marta Montoro, Stratospheric
Protection Division, at
montoro.marta@epa.gov. If the
application is submitted electronically,
applicants are requested to fax a signed
copy of Worksheet 1 to Marta Montoro
at (202) 343–2338 by the application
deadline.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
General Information: U.S. EPA
Stratospheric Ozone Information
Hotline, 1–800–296–1996; also https://
www.epa.gov/ozone/mbr.
Technical Information: Colwell Cook,
U.S. Environmental Protection Agency,
Office of Pesticide Programs (7503C),
1200 Pennsylvania Ave., NW.,
Washington, DC 20460, (703) 308–8146.
E-mail: cook.colwell@epa.gov.
Economic Information: Elisa Rim,
U.S. Environmental Protection Agency,
Office of Pesticide Programs (7503C),
1200 Pennsylvania Ave., NW.,
Washington, DC 20460, (703) 308–8123.
E-mail: rim.elisa@epa.gov.
Regulatory Information: Marta
Montoro, U.S. Environmental Protection
Agency, Stratospheric Protection
Division (6205J), 1200 Pennsylvania
Ave., NW., Washington, DC 20460, (202)
343–9321. E-mail:
Montoro.marta@epa.gov.
SUPPLEMENTARY INFORMATION:
Applications are due one month earlier
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
to EPA due to the compressed review
schedule for critical use exemptions in
the year 2007. The 19th Meeting of the
Parties is scheduled to be held in
September 2007, almost two months
earlier than previous meetings of the
parties which typically occur in
November or December. The EPA will
submit a nomination for critical uses
earlier than the end of January and will
shorten its own review process by one
month. In addition, in this notice, EPA
is notifying applicants that their
application process is being shortened
by one month with July 10th as the
deadline for applications. EPA also
renewed the Information Collection
Request (ICR) for the applications on
August 31, 2005. The ICR is now valid
through August 31, 2008. As a result of
the ICR renewal, the format and
numbering of the application
worksheets changed minimally.
Table of Contents
I. What do I need to know to respond to this
request for applications?
A. Who can respond to this request for
information?
B. Who can I contact to find out if a
consortium is submitting an application
form for my methyl bromide use?
C. How do I obtain an application form for
the methyl bromide critical use
exemption?
D. What alternatives must applicants
address when applying for a critical use
exemption?
E. What portions of the applications will be
considered confidential business
information?
F. Must I submit a ‘‘Notice of Intent to
Apply?’’
G. What if I submit an incomplete
application?
H. What if I already applied in 2002 and/
or 2003 and/or 2004?
II. What is the legal authority for the critical
use exemption?
A. What is the Clean Air Act (CAA)
authority for implementing the critical
use exemption to the methyl bromide
phaseout?
B. What is the Montreal Protocol authority
for granting a critical use exemption after
the methyl bromide phaseout?
III. How is the U.S. implementing the critical
use exemption?
A. When will the exemption become
available to U.S. users of methyl
bromide?
B. What is the projected timeline for the
critical use exemption application
process?
I. What do I need to know to respond
to this request for applications?
A. Who can respond to this request for
information?
Entities interested in obtaining a
critical use exemption must fill out the
application form available at https://
E:\FR\FM\26APN1.SGM
26APN1
Federal Register / Vol. 71, No. 80 / Wednesday, April 26, 2006 / Notices
www.epa.gov/ozone/mbr. The
application form may be submitted
either by a consortium representing
multiple users who have similar
circumstances or by individual users
who anticipate needing methyl bromide
in 2009 and beyond and believe there
are no technically and economically
feasible alternatives. EPA encourages
groups of users with similar
circumstances of use to submit a single
application (for example, any number of
pre-plant users with similar soil, pest,
and climatic conditions can join
together to submit a single application).
In some instances, state agencies will
assist users with the application process
(see discussion of voluntary state
involvement in Part I.B. below).
In addition to requesting information
from applicants for the critical use
exemption, this solicitation for
information provides an opportunity for
any interested party to provide EPA
with information on methyl bromide
alternatives (e.g., technical and/or
economic feasibility research). The
application form for the methyl bromide
critical use exemption and other
information on research relevant to
alternatives must be sent to the
addresses specified above or e-mailed to
the address specified above. The
applicant’s signature, which is required
in order for EPA to process your
application, is on Worksheet 1 of the
application. If you submit your
application electronically, you must fax
a signed copy of worksheet 1 to Marta
Montoro at (202) 343–2338.
wwhite on PROD1PC61 with NOTICES
B. Whom can I contact to find out if a
consortium is submitting an application
form for my methyl bromide use?
Please contact your local, state,
regional, or national commodity
association to determine whether they
plan to submit an application on behalf
of your commodity group.
Additionally, you should contact your
state regulatory agency (generally this
will be the State Department of
Agriculture or State Environmental
Protection Agency) to receive
information about their involvement in
the process. If your state agency has
chosen to participate, EPA encourages
all applicants to first submit their
applications to the state regulatory
agency, which will then forward them
to EPA. The National Pesticide
Information Center Web site (https://
ace.orst.edu/info/npic/state1.htm)
provides information on identifying the
lead pesticide agency in each state.
VerDate Aug<31>2005
16:58 Apr 25, 2006
Jkt 208001
C. How do I obtain an application form
for the methyl bromide critical use
exemption?
An application form for the methyl
bromide critical use exemption can be
obtained either in electronic or hardcopy form. EPA encourages use of the
electronic form. Applications can be
obtained in the following ways:
1. PDF format and Microsoft Excel at
EPA Web site: https://www.epa.gov/
ozone/mbr;
2. Hard copy ordered through the
Stratospheric Ozone Protection Hotline
at 1–800–296–1996;
3. Hard-copy format at Docket number
EPA–HQ–OAR–2003–0017. The Docket
is located in room B–102, EPA West
Building, U.S. Environmental Protection
Agency, 1301 Constitution Ave. NW.,
Washington, DC 20004. The Docket
Office is open from 8:30 a.m. until 4:30
p.m. Monday through Friday. A
reasonable fee may be charged by EPA
for copying docket materials.
D. What alternatives must applicants
address when applying for a critical use
exemption?
To support the assertion that a
specific use of methyl bromide is
‘‘critical,’’ applicants are expected to
demonstrate that there are no
technically and economically feasible
alternatives available to the user of
methyl bromide. The Parties to the
Montreal Protocol have developed an
‘‘International Index’’ of methyl
bromide alternatives which lists
chemical and non-chemical alternatives
by crop (https://www.epa.gov/ozone/
mbr/in_alt_in.html). The chemicals and
non-chemical practices included on this
index were identified by the
international technical advisory groups
under the Montreal Protocol: The
Methyl Bromide Technical Options
Committee (MBTOC) and the Technical
and Economic Assessment Panel
(TEAP). The MBTOC and the TEAP
determined that alternatives in the
International Index have the ‘‘technical
potential’’ to replace methyl bromide in
at least one circumstance of use on the
identified crop (Report of the Technical
and Economic Assessment Panel, 1997)
(https://www.teap.org/html/
teap_reports.html). In addition, the U.S.
Government has developed the U.S.
Index of Methyl Bromide Alternatives,
also listed by crop (https://www.epa.gov/
ozone/mbr/us_alt_in.html). The U.S.
Index reflects whether chemical
alternatives included in the
International Index have been registered
for use in the United States.
Applicants must address technical,
regulatory, and economic issues that
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
24699
limit the adoption of ‘‘chemical
alternatives’’ and combinations of
‘‘chemical’’ and ‘‘non-chemical
alternatives’’ listed for their crop within
the ‘‘U.S. Index’’ of Methyl Bromide
Alternatives. Applicants must also
address technical, regulatory, and
economic issues that limit the adoption
of ‘‘non-chemical alternatives’’ and
combinations of ‘‘chemical’’ and ‘‘nonchemical alternatives’’ listed for their
crop in the ‘‘International Index.’’
E. What portions of the applications will
be considered confidential business
information?
The person submitting information to
EPA in response to this Notice may
assert a business confidentiality claim
covering part or all of the information
by placing on (or attaching to) the
information, at the time it is submitted
to EPA, a cover sheet, stamped or typed
legend, or other suitable form of notice
employing language such as ‘‘trade
secret,’’ ‘‘proprietary,’’ or ‘‘company
confidential.’’ Allegedly confidential
portions of otherwise non-confidential
documents should be clearly identified
by the applicant, and may be submitted
separately to facilitate identification and
handling by EPA. If the applicant
desires confidential treatment only until
a certain date or until the occurrence of
a certain event, the notice should so
state. Information covered by a claim of
confidentiality will be disclosed by EPA
only to the extent, and by means of the
procedures, set forth under 40 CFR part
2, subpart B; 41 FR 36752, 43 FR 40000,
50 FR 51661. If no claim of
confidentiality accompanies the
information when it is received by EPA,
it may be made available to the public
by EPA without further notice to the
applicant.
If you are asserting a business
confidentiality claim covering part or all
of the information in the application,
please submit a non-confidential
version that EPA can place in the public
docket for reference by other interested
parties. Do not include on Worksheet 6
(formerly Worksheet 5, ‘‘Application
Summary’’) any information that you
wish to claim as confidential business
information. Any information on
Worksheet 5 is not considered
confidential and will not be treated as
such by the Agency. EPA will place a
copy of Worksheet 6 in the public
domain. EPA will place applications
that are not confidential business
information in the docket in their
entirety. Please note that claiming
business confidentiality may delay
EPA’s ability to review your application.
E:\FR\FM\26APN1.SGM
26APN1
24700
Federal Register / Vol. 71, No. 80 / Wednesday, April 26, 2006 / Notices
F. Must I submit a ‘‘Notice of Intent to
Apply?’’
II. What is the Legal Authority for the
critical use exemption?
A ‘‘Notice of Intent to Apply’’ is not
required, but would facilitate the
application review process. If EPA is
aware of the consortia and the
individuals who intend to submit
applications 30 days before the
application deadline, the technical
experts will be better positioned to
review the application. This notice may
be submitted to Marta Montoro at the
addresses above.
A. What is the Clean Air Act (CAA)
authority for implementing the critical
use exemption to the methyl bromide
phaseout?
In October 1998, the U.S. Congress
amended the Clean Air Act by adding
CAA sections 604(d)(6), 604(e)(3), and
604(h) (Section 764 of the 1999
Omnibus Consolidated and Emergency
Supplemental Appropriations Act (Pub.
L. No. 105–277; October 21, 1998)). The
amendment requires EPA to conform
the U.S. phaseout schedule for methyl
bromide to the provisions of the
Montreal Protocol for industrialized
countries. Specifically, the amendment
requires EPA to make regulatory
changes to implement the following
phaseout schedule:
25% reduction (from 1991 baseline)
in 1999.
50% reduction in 2001.
70% reduction in 2003.
100% reduction in 2005.
EPA published regulations in the
Federal Register on June 1, 1999 (64 FR
29240) and November 28, 2000 (65 FR
70795), instituting the phaseout
reductions in the production and import
of methyl bromide in accordance with
the schedule listed above. Additionally,
the 1998 amendment allowed EPA to
exempt the production and import of
methyl bromide from the phaseout for
critical uses starting January 1, 2005 ‘‘to
the extent consistent with the Montreal
Protocol’’ (section 764 of the 1999
Omnibus Consolidated and Emergency
Supplemental Appropriations Act (Pub.
L. 105–277, October 21, 1998), section
604(d)(6) of the Clean Air Act).
G. What if I submit an incomplete
application?
EPA will not accept any applications
postmarked after July 10, 2006. If the
application is postmarked by the
deadline but is incomplete or missing
any of the following data elements listed
in the ‘‘Re-Application Information
Document’’ available at https://
www.epa.gov/ozone/mbr EPA will not
accept the application and will not
include the application in the U.S.
nomination submitted for international
consideration. These required elements
include Worksheets 1, 2B, 2C, 2D, 4, 5,
and 6 (formerly Worksheet 5). EPA will
accept applications that are
substantially complete with only minor
errors. EPA reviewers may also call
applicants to further clarify their
application, even if it is complete.
All consortia or users who have not
applied to EPA in the previous year
(2005) must submit an entire completed
application with all worksheets.
wwhite on PROD1PC61 with NOTICES
H. What if I already previously applied
for a critical use exemption?
In March 2004 and in November 2004,
the Parties decided that critical use
exemptions would be granted for one
year. As a result, users must apply to
EPA for critical use exemptions on an
annual basis. However, if a user group
submitted a complete application to
EPA in 2004, the user is only required
to submit revised copies of the selected
worksheets listed above, though the
entire application with all worksheets
must be on file with EPA. A list of the
worksheets you must fill out each year
is detailed above and is also available at
https://www.epa.gov/ozone/mbr. The
remaining worksheets must only be
completed if any information has
changed since 2005. If a user submitted
a critical use exemption application to
EPA in 2002, 2003, or 2004 (first,
second or third rounds) but did not
submit an application in 2005 (fourth
round) then all worksheets in the
application must be submitted again in
their entirety.
VerDate Aug<31>2005
16:58 Apr 25, 2006
Jkt 208001
B. What is the Montreal Protocol
authority for granting a critical use
exemption after the methyl bromide
phaseout?
The Montreal Protocol provides an
exemption to the phaseout of methyl
bromide for critical uses in Article 2H,
paragraph 5. The Parties to the Protocol
included provisions for such an
exemption in recognition that
substitutes for methyl bromide may not
be available by 2005 for certain uses of
methyl bromide agreed by the Parties to
be ‘‘critical uses.’’
In their Ninth Meeting (1997), the
Parties to the Protocol agreed to
Decision IX/6, setting forth the
following criteria for a ‘‘critical use’’
determination:
(a) That a use of methyl bromide
should qualify as ‘‘critical’’ only if the
nominating Party determines that:
(i) The specific use is critical because
the lack of availability of methyl
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
bromide for that use would result in a
significant market disruption; and
(ii) There are no technically and
economically feasible alternatives or
substitutes available to the user that are
acceptable from the standpoint of
environment and health and are suitable
to the crops and circumstances of the
nomination.
(b) That production and consumption,
if any, of methyl bromide for a critical
use should be permitted only if:
(i) All technically and economically
feasible steps have been taken to
minimize the critical use and any
associated emission of methyl bromide;
(ii) Methyl bromide is not available in
sufficient quantity and quality from
existing stocks of banked or recycled
methyl bromide, also bearing in mind
the developing countries’ need for
methyl bromide;
(iii) It is demonstrated that an
appropriate effort is being made to
evaluate, commercialize and secure
national regulatory approval of
alternatives and substitutes, taking into
consideration the circumstances of the
particular nomination * * *. NonArticle 5 Parties [e.g., the U.S.] must
demonstrate that research programmes
are in place to develop and deploy
alternatives and substitutes * * *.
In the context of the phaseout
program, the use of the term
consumption may be misleading.
Consumption does not mean the ‘‘use’’
of a controlled substance, but rather is
defined as the formula: consumption =
production + imports ¥exports, of
controlled substances (Article 1 of the
Protocol and Section 601 of the CAA).
A Class I controlled substance that was
produced or imported through the
expenditure of allowances prior to its
phaseout date can continue to be used
by industry and the public after that
specific chemical’s phaseout under
EPA’s phaseout regulations, unless
otherwise precluded under separate
regulations.
In addition to the language quoted
above, the Parties further agreed to
request the TEAP to review nominations
and make recommendations for
approval based on the criteria
established in paragraphs (a)(ii) and (b)
of Decision IX/6.
E:\FR\FM\26APN1.SGM
26APN1
Federal Register / Vol. 71, No. 80 / Wednesday, April 26, 2006 / Notices
III. How does the U.S. implement the
critical use exemption?
ENVIRONMENTAL PROTECTION
AGENCY
B. Under the provisions of both the CAA
and the Montreal Protocol, the critical
use exemption became available to
approved users on January 1, 2005.
Allowances for subsequent years are
authorized through regulations. The
critical use exemption process has an
international component and a
domestic component.
[EPA–HQ–OPPT–2006–0348; FRL–8060–8]
The projected schedule for the next
three years is as follows:
April 26, 2006—Solicit applications for
the methyl bromide critical use
exemption for 2009 and beyond.
July 10, 2006—Deadline for submitting
critical use exemption applications to
EPA.
Fall 2006—U.S. Government (EPA,
Department of State, U.S. Department
of Agriculture, and other interested
federal agencies) create U.S. critical
use nomination package.
January 31, 2007 but earlier December
2006 deadline strongly encouraged for
this year—Deadline for U.S.
Government to submit U.S.
nomination package to the Protocol
Parties.
Early 2007—Review of critical use
nomination packages by Technical
and Economic Assessment Panel
(TEAP) and Methyl Bromide
Technical Options Committee
(MBTOC).
Mid 2007—Parties consider TEAP/
MBTOC recommendations.
September 2007—Parties authorize
critical use exemptions for production
and consumption in 2008
(supplemental request) and 2009.
Early-Mid 2008—EPA publishes
proposed rule and final rule for 2008
supplemental request, if applicable.
Mid 2008—EPA publishes proposed
rule for allocating critical use
exemptions in the U.S. for 2009.
Late 2008—EPA publishes final rule
allocating critical use exemptions in
the U.S. for the 2009 control period.
January 1, 2009—Critical use exemption
permits limited production and
import of methyl bromide for specific
uses for the 2009 control period.
wwhite on PROD1PC61 with NOTICES
Authority: 42 U.S.C. 7414, 7601, 7671–
7671q.
Dated: April 11, 2006.
Brian J. McLean,
Director, Office of Atmospheric Programs.
[FR Doc. E6–6256 Filed 4–25–06; 8:45 am]
BILLING CODE 6560–50–P
VerDate Aug<31>2005
16:58 Apr 25, 2006
Jkt 208001
Certain New Chemicals; Receipt and
Status Information
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
SUMMARY: Section 5 of the Toxic
Substances Control Act (TSCA) requires
any person who intends to manufacture
(defined by statute to include import) a
new chemical (i.e., a chemical not on
the TSCA Inventory) to notify EPA and
comply with the statutory provisions
pertaining to the manufacture of new
chemicals. Under sections 5(d)(2) and
5(d)(3) of TSCA, EPA is required to
publish a notice of receipt of a
premanufacture notice (PMN) or an
application for a test marketing
exemption (TME), and to publish
periodic status reports on the chemicals
under review and the receipt of notices
of commencement to manufacture those
chemicals. This status report, which
covers the period from March 27, 2006
to April 7, 2007, consists of the PMNs
pending or expired, and the notices of
commencement to manufacture a new
chemical that the Agency has received
under TSCA section 5 during this time
period.
DATES: Comments identified by the
specific PMN number or TME number,
must be received on or before May 26,
2006.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
no. EPA–HQ–OPPT–2006–0348, by one
of the following methods.
• https://www.regulations.gov. Follow
the on-line instructions for submitting
comments.
• Mail: Document Control Office
(7407M), Office of Pollution Prevention
and Toxics (OPPT), Environmental
Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460–
0001.
• Hand Delivery: OPPT Document
Control Office (DCO), EPA East Bldg.,
Rm. 6428, 1201 Constitution Ave., NW.,
Washington, DC. Attention: Docket ID
number EPA–HQ–OPPT–2006–0348.
The DCO is open from 8 a.m. to 4 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
DCO is (202) 564–8930. Such deliveries
are only accepted during the Docket’s
normal hours of operation, and special
arrangements should be made for
deliveries of boxed information.
• Instructions: Direct your comments
to docket ID number EPA–HQ–OPPT–
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
24701
2006–0348. EPA’s policy is that all
comments received will be included in
the public docket without change and
may be made available online at https://
www.regulations.gov, including any
personal information provided, unless
the comment includes information
claimed to be Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Do not submit information that you
consider to be CBI or otherwise
protected through regulations.gov or email. The regulations.gov Web site is an
‘‘anonymous access’’ systems, which
means EPA will not know your identity
or contact information unless you
provide it in the body of your comment.
If you send an e-mail comment directly
to EPA without going through
regulations.gov your e-mail address will
be automatically captured and included
as part of the comment that is placed in
the public docket and made available on
the Internet. If you submit an electronic
comment, EPA recommends that you
include your name and other contact
information in the body of your
comment and with any disk or CD ROM
you submit. If EPA cannot read your
comment due to technical difficulties
and cannot contact you for clarification,
EPA may not be able to consider your
comment. Electronic files should avoid
the use of special characters, any form
of encryption, and be free of any defects
or viruses.
Docket: All documents in the docket
are listed in the regulations.gov index.
Although listed in the index, some
information is not publicly available,
i.e., CBI or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available electronically through
regulations.gov or in hard copy at the
OPPT Docket, EPA Docket Center (EPA/
DC), EPA West, Room B102, 1301
Constitution Ave., NW., Washington,
DC. The EPA Docket Center Public
Reading Room is open from 8:30 a.m. to
4:30 p.m., Monday through Friday,
excluding legal holidays. The telephone
number for the Public Reading Room is
(202) 566–1744, and the telephone
number for the OPPT Docket is (202)
566–0280.
FOR FURTHER INFORMATION CONTACT:
Colby Lintner, Regulatory Coordinator,
Environmental Assistance Division,
Office of Pollution Prevention and
Toxics (7408M), Environmental
Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460–
E:\FR\FM\26APN1.SGM
26APN1
Agencies
[Federal Register Volume 71, Number 80 (Wednesday, April 26, 2006)]
[Notices]
[Pages 24698-24701]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-6256]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OAR-2003-0017; FRL-8162-2]
Protection of Stratospheric Ozone: Request for Critical Use
Exemption Applications for the Years 2008 and 2009
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of solicitation of applications and information on
alternatives.
-----------------------------------------------------------------------
SUMMARY: EPA is soliciting applications for the critical use exemption
from the phaseout of methyl bromide for 2009 and beyond. In addition,
those applicants who missed last year's deadline to apply for a
critical use exemption for the year 2008 may file a supplemental
application in response to the notice. This exemption is an annual
exemption and all entities interested in obtaining a critical use
exemption must provide EPA with technical and economic information to
support a ``critical use'' claim, and must do so by the deadline
specified in this notice even if they have previously applied for an
exemption. This notice also invites interested parties to provide EPA
with new data on the technical and economic feasibility of methyl
bromide alternatives.
DATES: Applications for the critical use exemption must be postmarked
on or before July 10, 2006. Applications for an exemption are due one
month earlier to EPA this year to reflect the compressed schedule for
review of applications in 2007.
ADDRESSES: Applications for the methyl bromide critical use exemption
should be submitted in duplicate (two copies) by mail to: U.S.
Environmental Protection Agency, Office of Air and Radiation,
Stratospheric Protection Division, Attention: Marta Montoro/Methyl
Bromide Review Team, Mail Code 6205J, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460 or by courier delivery (other than U.S. Post
Office overnight) to: U.S. Environmental Protection Agency, Office of
Air and Radiation, Stratospheric Protection Division, Attention: Marta
Montoro/Methyl Bromide Review Team, 1310 L St., NW., Room 827L,
Washington, DC 20005. EPA also encourages users to submit their
applications electronically to Marta Montoro, Stratospheric Protection
Division, at montoro.marta@epa.gov. If the application is submitted
electronically, applicants are requested to fax a signed copy of
Worksheet 1 to Marta Montoro at (202) 343-2338 by the application
deadline.
FOR FURTHER INFORMATION CONTACT:
General Information: U.S. EPA Stratospheric Ozone Information
Hotline, 1-800-296-1996; also https://www.epa.gov/ozone/mbr.
Technical Information: Colwell Cook, U.S. Environmental Protection
Agency, Office of Pesticide Programs (7503C), 1200 Pennsylvania Ave.,
NW., Washington, DC 20460, (703) 308-8146. E-mail:
cook.colwell@epa.gov.
Economic Information: Elisa Rim, U.S. Environmental Protection
Agency, Office of Pesticide Programs (7503C), 1200 Pennsylvania Ave.,
NW., Washington, DC 20460, (703) 308-8123. E-mail: rim.elisa@epa.gov.
Regulatory Information: Marta Montoro, U.S. Environmental
Protection Agency, Stratospheric Protection Division (6205J), 1200
Pennsylvania Ave., NW., Washington, DC 20460, (202) 343-9321. E-mail:
Montoro.marta@epa.gov.
SUPPLEMENTARY INFORMATION: Applications are due one month earlier to
EPA due to the compressed review schedule for critical use exemptions
in the year 2007. The 19th Meeting of the Parties is scheduled to be
held in September 2007, almost two months earlier than previous
meetings of the parties which typically occur in November or December.
The EPA will submit a nomination for critical uses earlier than the end
of January and will shorten its own review process by one month. In
addition, in this notice, EPA is notifying applicants that their
application process is being shortened by one month with July 10th as
the deadline for applications. EPA also renewed the Information
Collection Request (ICR) for the applications on August 31, 2005. The
ICR is now valid through August 31, 2008. As a result of the ICR
renewal, the format and numbering of the application worksheets changed
minimally.
Table of Contents
I. What do I need to know to respond to this request for
applications?
A. Who can respond to this request for information?
B. Who can I contact to find out if a consortium is submitting
an application form for my methyl bromide use?
C. How do I obtain an application form for the methyl bromide
critical use exemption?
D. What alternatives must applicants address when applying for a
critical use exemption?
E. What portions of the applications will be considered
confidential business information?
F. Must I submit a ``Notice of Intent to Apply?''
G. What if I submit an incomplete application?
H. What if I already applied in 2002 and/or 2003 and/or 2004?
II. What is the legal authority for the critical use exemption?
A. What is the Clean Air Act (CAA) authority for implementing
the critical use exemption to the methyl bromide phaseout?
B. What is the Montreal Protocol authority for granting a
critical use exemption after the methyl bromide phaseout?
III. How is the U.S. implementing the critical use exemption?
A. When will the exemption become available to U.S. users of
methyl bromide?
B. What is the projected timeline for the critical use exemption
application process?
I. What do I need to know to respond to this request for applications?
A. Who can respond to this request for information?
Entities interested in obtaining a critical use exemption must fill
out the application form available at https://
[[Page 24699]]
www.epa.gov/ozone/mbr. The application form may be submitted either by
a consortium representing multiple users who have similar circumstances
or by individual users who anticipate needing methyl bromide in 2009
and beyond and believe there are no technically and economically
feasible alternatives. EPA encourages groups of users with similar
circumstances of use to submit a single application (for example, any
number of pre-plant users with similar soil, pest, and climatic
conditions can join together to submit a single application). In some
instances, state agencies will assist users with the application
process (see discussion of voluntary state involvement in Part I.B.
below).
In addition to requesting information from applicants for the
critical use exemption, this solicitation for information provides an
opportunity for any interested party to provide EPA with information on
methyl bromide alternatives (e.g., technical and/or economic
feasibility research). The application form for the methyl bromide
critical use exemption and other information on research relevant to
alternatives must be sent to the addresses specified above or e-mailed
to the address specified above. The applicant's signature, which is
required in order for EPA to process your application, is on Worksheet
1 of the application. If you submit your application electronically,
you must fax a signed copy of worksheet 1 to Marta Montoro at (202)
343-2338.
B. Whom can I contact to find out if a consortium is submitting an
application form for my methyl bromide use?
Please contact your local, state, regional, or national commodity
association to determine whether they plan to submit an application on
behalf of your commodity group.
Additionally, you should contact your state regulatory agency
(generally this will be the State Department of Agriculture or State
Environmental Protection Agency) to receive information about their
involvement in the process. If your state agency has chosen to
participate, EPA encourages all applicants to first submit their
applications to the state regulatory agency, which will then forward
them to EPA. The National Pesticide Information Center Web site (http:/
/ace.orst.edu/info/npic/state1.htm) provides information on identifying
the lead pesticide agency in each state.
C. How do I obtain an application form for the methyl bromide critical
use exemption?
An application form for the methyl bromide critical use exemption
can be obtained either in electronic or hard-copy form. EPA encourages
use of the electronic form. Applications can be obtained in the
following ways:
1. PDF format and Microsoft Excel at EPA Web site: https://
www.epa.gov/ozone/mbr;
2. Hard copy ordered through the Stratospheric Ozone Protection
Hotline at 1-800-296-1996;
3. Hard-copy format at Docket number EPA-HQ-OAR-2003-0017. The
Docket is located in room B-102, EPA West Building, U.S. Environmental
Protection Agency, 1301 Constitution Ave. NW., Washington, DC 20004.
The Docket Office is open from 8:30 a.m. until 4:30 p.m. Monday through
Friday. A reasonable fee may be charged by EPA for copying docket
materials.
D. What alternatives must applicants address when applying for a
critical use exemption?
To support the assertion that a specific use of methyl bromide is
``critical,'' applicants are expected to demonstrate that there are no
technically and economically feasible alternatives available to the
user of methyl bromide. The Parties to the Montreal Protocol have
developed an ``International Index'' of methyl bromide alternatives
which lists chemical and non-chemical alternatives by crop (https://
www.epa.gov/ozone/mbr/in_alt_in.html). The chemicals and non-chemical
practices included on this index were identified by the international
technical advisory groups under the Montreal Protocol: The Methyl
Bromide Technical Options Committee (MBTOC) and the Technical and
Economic Assessment Panel (TEAP). The MBTOC and the TEAP determined
that alternatives in the International Index have the ``technical
potential'' to replace methyl bromide in at least one circumstance of
use on the identified crop (Report of the Technical and Economic
Assessment Panel, 1997) (https://www.teap.org/html/teap_reports.html).
In addition, the U.S. Government has developed the U.S. Index of Methyl
Bromide Alternatives, also listed by crop (https://www.epa.gov/ozone/
mbr/us_alt_in.html). The U.S. Index reflects whether chemical
alternatives included in the International Index have been registered
for use in the United States.
Applicants must address technical, regulatory, and economic issues
that limit the adoption of ``chemical alternatives'' and combinations
of ``chemical'' and ``non-chemical alternatives'' listed for their crop
within the ``U.S. Index'' of Methyl Bromide Alternatives. Applicants
must also address technical, regulatory, and economic issues that limit
the adoption of ``non-chemical alternatives'' and combinations of
``chemical'' and ``non-chemical alternatives'' listed for their crop in
the ``International Index.''
E. What portions of the applications will be considered confidential
business information?
The person submitting information to EPA in response to this Notice
may assert a business confidentiality claim covering part or all of the
information by placing on (or attaching to) the information, at the
time it is submitted to EPA, a cover sheet, stamped or typed legend, or
other suitable form of notice employing language such as ``trade
secret,'' ``proprietary,'' or ``company confidential.'' Allegedly
confidential portions of otherwise non-confidential documents should be
clearly identified by the applicant, and may be submitted separately to
facilitate identification and handling by EPA. If the applicant desires
confidential treatment only until a certain date or until the
occurrence of a certain event, the notice should so state. Information
covered by a claim of confidentiality will be disclosed by EPA only to
the extent, and by means of the procedures, set forth under 40 CFR part
2, subpart B; 41 FR 36752, 43 FR 40000, 50 FR 51661. If no claim of
confidentiality accompanies the information when it is received by EPA,
it may be made available to the public by EPA without further notice to
the applicant.
If you are asserting a business confidentiality claim covering part
or all of the information in the application, please submit a non-
confidential version that EPA can place in the public docket for
reference by other interested parties. Do not include on Worksheet 6
(formerly Worksheet 5, ``Application Summary'') any information that
you wish to claim as confidential business information. Any information
on Worksheet 5 is not considered confidential and will not be treated
as such by the Agency. EPA will place a copy of Worksheet 6 in the
public domain. EPA will place applications that are not confidential
business information in the docket in their entirety. Please note that
claiming business confidentiality may delay EPA's ability to review
your application.
[[Page 24700]]
F. Must I submit a ``Notice of Intent to Apply?''
A ``Notice of Intent to Apply'' is not required, but would
facilitate the application review process. If EPA is aware of the
consortia and the individuals who intend to submit applications 30 days
before the application deadline, the technical experts will be better
positioned to review the application. This notice may be submitted to
Marta Montoro at the addresses above.
G. What if I submit an incomplete application?
EPA will not accept any applications postmarked after July 10,
2006. If the application is postmarked by the deadline but is
incomplete or missing any of the following data elements listed in the
``Re-Application Information Document'' available at https://
www.epa.gov/ozone/mbr EPA will not accept the application and will not
include the application in the U.S. nomination submitted for
international consideration. These required elements include Worksheets
1, 2B, 2C, 2D, 4, 5, and 6 (formerly Worksheet 5). EPA will accept
applications that are substantially complete with only minor errors.
EPA reviewers may also call applicants to further clarify their
application, even if it is complete.
All consortia or users who have not applied to EPA in the previous
year (2005) must submit an entire completed application with all
worksheets.
H. What if I already previously applied for a critical use exemption?
In March 2004 and in November 2004, the Parties decided that
critical use exemptions would be granted for one year. As a result,
users must apply to EPA for critical use exemptions on an annual basis.
However, if a user group submitted a complete application to EPA in
2004, the user is only required to submit revised copies of the
selected worksheets listed above, though the entire application with
all worksheets must be on file with EPA. A list of the worksheets you
must fill out each year is detailed above and is also available at
https://www.epa.gov/ozone/mbr. The remaining worksheets must only be
completed if any information has changed since 2005. If a user
submitted a critical use exemption application to EPA in 2002, 2003, or
2004 (first, second or third rounds) but did not submit an application
in 2005 (fourth round) then all worksheets in the application must be
submitted again in their entirety.
II. What is the Legal Authority for the critical use exemption?
A. What is the Clean Air Act (CAA) authority for implementing the
critical use exemption to the methyl bromide phaseout?
In October 1998, the U.S. Congress amended the Clean Air Act by
adding CAA sections 604(d)(6), 604(e)(3), and 604(h) (Section 764 of
the 1999 Omnibus Consolidated and Emergency Supplemental Appropriations
Act (Pub. L. No. 105-277; October 21, 1998)). The amendment requires
EPA to conform the U.S. phaseout schedule for methyl bromide to the
provisions of the Montreal Protocol for industrialized countries.
Specifically, the amendment requires EPA to make regulatory changes to
implement the following phaseout schedule:
25% reduction (from 1991 baseline) in 1999.
50% reduction in 2001.
70% reduction in 2003.
100% reduction in 2005.
EPA published regulations in the Federal Register on June 1, 1999
(64 FR 29240) and November 28, 2000 (65 FR 70795), instituting the
phaseout reductions in the production and import of methyl bromide in
accordance with the schedule listed above. Additionally, the 1998
amendment allowed EPA to exempt the production and import of methyl
bromide from the phaseout for critical uses starting January 1, 2005
``to the extent consistent with the Montreal Protocol'' (section 764 of
the 1999 Omnibus Consolidated and Emergency Supplemental Appropriations
Act (Pub. L. 105-277, October 21, 1998), section 604(d)(6) of the Clean
Air Act).
B. What is the Montreal Protocol authority for granting a critical use
exemption after the methyl bromide phaseout?
The Montreal Protocol provides an exemption to the phaseout of
methyl bromide for critical uses in Article 2H, paragraph 5. The
Parties to the Protocol included provisions for such an exemption in
recognition that substitutes for methyl bromide may not be available by
2005 for certain uses of methyl bromide agreed by the Parties to be
``critical uses.''
In their Ninth Meeting (1997), the Parties to the Protocol agreed
to Decision IX/6, setting forth the following criteria for a ``critical
use'' determination:
(a) That a use of methyl bromide should qualify as ``critical''
only if the nominating Party determines that:
(i) The specific use is critical because the lack of availability
of methyl bromide for that use would result in a significant market
disruption; and
(ii) There are no technically and economically feasible
alternatives or substitutes available to the user that are acceptable
from the standpoint of environment and health and are suitable to the
crops and circumstances of the nomination.
(b) That production and consumption, if any, of methyl bromide for
a critical use should be permitted only if:
(i) All technically and economically feasible steps have been taken
to minimize the critical use and any associated emission of methyl
bromide;
(ii) Methyl bromide is not available in sufficient quantity and
quality from existing stocks of banked or recycled methyl bromide, also
bearing in mind the developing countries' need for methyl bromide;
(iii) It is demonstrated that an appropriate effort is being made
to evaluate, commercialize and secure national regulatory approval of
alternatives and substitutes, taking into consideration the
circumstances of the particular nomination * * *. Non-Article 5 Parties
[e.g., the U.S.] must demonstrate that research programmes are in place
to develop and deploy alternatives and substitutes * * *.
In the context of the phaseout program, the use of the term
consumption may be misleading. Consumption does not mean the ``use'' of
a controlled substance, but rather is defined as the formula:
consumption = production + imports -exports, of controlled substances
(Article 1 of the Protocol and Section 601 of the CAA). A Class I
controlled substance that was produced or imported through the
expenditure of allowances prior to its phaseout date can continue to be
used by industry and the public after that specific chemical's phaseout
under EPA's phaseout regulations, unless otherwise precluded under
separate regulations.
In addition to the language quoted above, the Parties further
agreed to request the TEAP to review nominations and make
recommendations for approval based on the criteria established in
paragraphs (a)(ii) and (b) of Decision IX/6.
[[Page 24701]]
III. How does the U.S. implement the critical use exemption?
B. Under the provisions of both the CAA and the Montreal Protocol, the
critical use exemption became available to approved users on January 1,
2005. Allowances for subsequent years are authorized through
regulations. The critical use exemption process has an international
component and a domestic component.
The projected schedule for the next three years is as follows:
April 26, 2006--Solicit applications for the methyl bromide critical
use exemption for 2009 and beyond.
July 10, 2006--Deadline for submitting critical use exemption
applications to EPA.
Fall 2006--U.S. Government (EPA, Department of State, U.S. Department
of Agriculture, and other interested federal agencies) create U.S.
critical use nomination package.
January 31, 2007 but earlier December 2006 deadline strongly encouraged
for this year--Deadline for U.S. Government to submit U.S. nomination
package to the Protocol Parties.
Early 2007--Review of critical use nomination packages by Technical and
Economic Assessment Panel (TEAP) and Methyl Bromide Technical Options
Committee (MBTOC).
Mid 2007--Parties consider TEAP/MBTOC recommendations.
September 2007--Parties authorize critical use exemptions for
production and consumption in 2008 (supplemental request) and 2009.
Early-Mid 2008--EPA publishes proposed rule and final rule for 2008
supplemental request, if applicable.
Mid 2008--EPA publishes proposed rule for allocating critical use
exemptions in the U.S. for 2009.
Late 2008--EPA publishes final rule allocating critical use exemptions
in the U.S. for the 2009 control period.
January 1, 2009--Critical use exemption permits limited production and
import of methyl bromide for specific uses for the 2009 control period.
Authority: 42 U.S.C. 7414, 7601, 7671-7671q.
Dated: April 11, 2006.
Brian J. McLean,
Director, Office of Atmospheric Programs.
[FR Doc. E6-6256 Filed 4-25-06; 8:45 am]
BILLING CODE 6560-50-P